593
Views
18
CrossRef citations to date
0
Altmetric
Original Articles: Research

The function of a novel immunophenotype candidate molecule PD-1 in chronic lymphocytic leukemia

, , , , , , , , , , , & show all
Pages 2908-2913 | Received 15 Oct 2014, Accepted 06 Feb 2015, Published online: 14 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bei Hu, Loretta J. Nastoupil, Sanam Loghavi, Jason R. Westin, Beenu Thakral, Luis E. Fayad, Fredrick Hagemeister, Sattva Neelapu, Felipe Samaniego, Hun J. Lee, Michael L. Wang, Michelle Fanale, Nathan Fowler & Yasuhiro Oki. (2020) De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era. Leukemia & Lymphoma 61:2, pages 328-336.
Read now
Pawel Robak, Piotr Smolewski & Tadeusz Robak. (2015) Emerging immunological drugs for chronic lymphocytic leukemia. Expert Opinion on Emerging Drugs 20:3, pages 423-447.
Read now

Articles from other publishers (16)

O. N. Selyutina, I. B. Lysenko, N. K. Guskova, I. A. Novikova, E. Yu. Zlatnik, T. F. Pushkareva, N. V. Nikolaeva, I. A. Kamaeva, N. Yu. Samaneva & E. A. Kapuza. (2023) Expression of LAG-3 on B-lymphocytes as a marker for prediction of response to therapy in patients with chronic lymphocytic leukemia. Siberian journal of oncology 22:2, pages 34-42.
Crossref
Kensuke NakaoMomoko NishikoriMasakazu Fujimoto, Hiroshi ArimaHironori Haga & Akifumi Takaori-Kondo. (2023) Concurrent development of small lymphocytic lymphoma and lung cancer: A report of two cases and a review of the literature. Journal of Clinical and Experimental Hematopathology 63:2, pages 132-138.
Crossref
Ayfer GEDÜK, Özgür MEHTAP, Elif Birtaş ATEŞOĞLU, Pinar TARKUN, Esra TERZİ DEMİRSOY, Meral ULUKÖYLÜ MENGÜÇ, Serkan ÜNAL, Sinan MERSİN, Abdullah HACIHANEFİOĞLU, Tülin BURHANOĞLU & Gülçin GACAR. (2021) PD-1/PD-L1 Expression Levels and Prognostic Significance in Chronic Lymphocytic Leukemia. Acibadem Universitesi Saglik Bilimleri Dergisi 12:2.
Crossref
Shahad K. Alsaiari, Somayah S. Qutub, Shichao Sun, Walaa Baslyman, Mansour Aldehaiman, Mram Alyami, Abdulaziz Almalik, Rabih Halwani, Jasmeen Merzaban, Zhengwei Mao & Niveen M. Khashab. (2021) Sustained and targeted delivery of checkpoint inhibitors by metal-organic frameworks for cancer immunotherapy. Science Advances 7:4.
Crossref
Marta Wagner, Monika Jasek & Lidia Karabon. (2021) Immune Checkpoint Molecules—Inherited Variations as Markers for Cancer Risk. Frontiers in Immunology 11.
Crossref
Mani Ramzi, Nargess Arandi, Mahdiyar Iravani Saadi, Ramin Yaghobi & Bita Geramizadeh. (2020) Genetic Variation of Costimulatory Molecules, Including Cytotoxic T-Lymphocyte Antigen 4, Inducible T-Cell Costimulator, Cluster Differentiation 28, and Programmed Cell Death 1 Genes, in Iranian Patients With Leukemia. Experimental and Clinical Transplantation 18:6, pages 719-724.
Crossref
Francesca Arruga, Benjamin Baffour Gyau, Andrea Iannello, Nicoletta Vitale, Tiziana Vaisitti & Silvia Deaglio. (2020) Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions. International Journal of Molecular Sciences 21:5, pages 1825.
Crossref
J. Karolova, M. Radek, K. Helman, M. Spacek, M. Trneny & Pavel Klener. (2020) PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population. Folia Biologica 66:4, pages 117-122.
Crossref
Yiting Wang, Ping Wang & Jie Xu. 2020. Regulation of Cancer Immune Checkpoints. Regulation of Cancer Immune Checkpoints 347 398 .
Mixue Xie, Xianbo Huang, Xiujin Ye & Wenbin Qian. (2019) Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma. International Immunopharmacology 77, pages 105999.
Crossref
Krzysztof Giannopoulos. (2019) Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia. Journal of Clinical Medicine 8:2, pages 236.
Crossref
Aneta Malesa, Justyna Nowak, Katarzyna Skórka, Marta Karp & Krzysztof Giannopoulos. (2018) Immunoterapia z użyciem przeciwciał monoklonalnych ukierunkowanych na szlak PD-1/PD-L1 w chorobach nowotworowych. Acta Haematologica Polonica 49:4, pages 207-227.
Crossref
Djordje Atanackovic & Tim Luetkens. (2018) Biomarkers for checkpoint inhibition in hematologic malignancies. Seminars in Cancer Biology 52, pages 198-206.
Crossref
Zijun Y. Xu-MonetteJianfeng Zhou & Ken H. Young. (2018) PD-1 expression and clinical PD-1 blockade in B-cell lymphomas. Blood 131:1, pages 68-83.
Crossref
Darima Semunkoevna Badmazhapova, I.V. Gal'tseva & E.E. Zvonkov. (2018) Immunological Synapse in the Biology of Chronic Lymphocytic Leukemia. Clinical oncohematology 11:4, pages 313-318.
Crossref
Wei Ding, Betsy R. LaPlantTimothy G. Call, Sameer A. Parikh, Jose F. LeisRong HeTait D. Shanafelt, Sutapa Sinha, Jennifer Le-RademacherAndrew L. FeldmanThomas M. Habermann, Thomas E. Witzig, Gregory A. WisemanYi Lin, Erik AsmusGrzegorz S. Nowakowski, Michael J. Conte, Deborah A. Bowen, Casey N. Aitken, Daniel L. Van Dyke, Patricia T. Greipp, Xin Liu, Xiaosheng Wu, Henan Zhang, Charla R. Secreto, Shulan TianEsteban BraggioLinda E. Wellik, Ivana Micallef, David S. ViswanathaHuihuang YanAsher A. Chanan-Khan, Neil E. Kay, Haidong Dong & Stephen M. Ansell. (2017) Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood 129:26, pages 3419-3427.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.